Avexo Pharmaceuticals is transforming the field of metabolomics through advanced experimental techniques to identify key metabolites that drive maternal immunity. Our groundbreaking research has uncovered a unique biomarker critical for immune maintenance, presenting a new frontier for targeted therapies and diagnostics. This discovery not only bridges maternal health and oncology but also enables the development of precision medicine solutions that enhance outcomes for both mothers and cancer patients. We are committed to creating transformative care solutions that deliver a profound global health impact and new opportunities for medical innovation.